Jafar Al‐Mondhiry
YOU?
Author Swipe
View article: Artful Oncology: A Comprehensive Psychosocial Oncology Curriculum for Hematology/Oncology Fellows
Artful Oncology: A Comprehensive Psychosocial Oncology Curriculum for Hematology/Oncology Fellows Open
PURPOSE Forty-six percent of patients with cancer experience significant psychosocial distress, a factor linked to higher morbidity, mortality, and costs of care. Oncologists also face high psychosocial distress, particularly during fellow…
View article: Navigating Challenges in Palliative Care: A Survey on ASCO Guideline Adherence Among Health Care Providers in Low- and Middle-Income Countries
Navigating Challenges in Palliative Care: A Survey on ASCO Guideline Adherence Among Health Care Providers in Low- and Middle-Income Countries Open
PURPOSE Integrating palliative care into oncology is essential, yet disparities in access and quality persist, particularly in low- and middle-income countries (LMICs). The ASCO guidelines advocate for early, routine, interdisciplinary pal…
View article: Listening “At the Bedside”: Podcasts as an Emerging Tool for Medical Ethics Education
Listening “At the Bedside”: Podcasts as an Emerging Tool for Medical Ethics Education Open
Medical ethics education is crucial for medical students and trainees, helping to shape attitudes, beliefs, values, and professional identities. Exploration of ethical dilemmas and approaches to resolving them provides a broader understand…
View article: Pseudoprogression of Cutaneous Squamous Cell Carcinoma Invading the Super Vermillion Border Following Programmed Death-1 Inhibitor Monotherapy
Pseudoprogression of Cutaneous Squamous Cell Carcinoma Invading the Super Vermillion Border Following Programmed Death-1 Inhibitor Monotherapy Open
A 55-year-old woman with a moderately differentiated cutaneous squamous cell carcinoma (cSCC) of the upper lip experienced initial tumour growth and new lymphadenopathy after starting immunotherapy with Cemiplimab, but achieved complete re…
View article: Complete Resolution of Bulky Cutaneous Squamous Cell Carcinoma by Programmed Death-1 Inhibitor
Complete Resolution of Bulky Cutaneous Squamous Cell Carcinoma by Programmed Death-1 Inhibitor Open
A 94-year-old White man presented for the treatment of a recurrent cutaneous squamous cell carcinoma of the forehead. The lesion started 1 year ago and was treated initially with electrodesiccation and curettage followed by topical fluorou…
View article: Co-created Mobile Apps for Palliative Care Using Community-Partnered Participatory Research: Development and Usability Study
Co-created Mobile Apps for Palliative Care Using Community-Partnered Participatory Research: Development and Usability Study Open
Background Open design formats for mobile apps help clinicians and stakeholders bring their needs to direct, co-creative solutions. Palliative care for patients with advanced cancers requires intensive monitoring and support and remains an…
View article: Co-created Mobile Apps for Palliative Care Using Community-Partnered Participatory Research: Development and Usability Study (Preprint)
Co-created Mobile Apps for Palliative Care Using Community-Partnered Participatory Research: Development and Usability Study (Preprint) Open
BACKGROUND Open design formats for mobile apps help clinicians and stakeholders bring their needs to direct, co-creative solutions. Palliative care for patients with advanced cancers requires intensive monitoring and support and remains a…
View article: Hematologic Chaos in Lupus Flare: A Case of Fulminant and Simultaneous Antiphospholipid, Anti-ADAMTS13, and Red Blood Cell Autoantibodies
Hematologic Chaos in Lupus Flare: A Case of Fulminant and Simultaneous Antiphospholipid, Anti-ADAMTS13, and Red Blood Cell Autoantibodies Open
Systemic lupus erythematosus may present with several distinct autoimmune phenomena simultaneously. We report a patient presenting with three serious hematologic disorders: thrombotic thrombocytopenic purpura, catastrophic antiphospholipid…
View article: Disparities in Time to Treatment ofHepatocellular Carcinoma in Patients withHepatitis B Virus versus Hepatitis C Virus
Disparities in Time to Treatment ofHepatocellular Carcinoma in Patients withHepatitis B Virus versus Hepatitis C Virus Open
Background: The most common risk factors for hepatocellular carcinoma (HCC) are hepatitis B (HBV) and C (HCV). Patients with HCV related HCC have biology and outcomes distinct from HBV related HCC. We evaluated whether there is a differenc…